Amgen Mutual Funds | StatInvestor

Health Care & Life Sciences » Biotechnology | Amgen Inc.

Amgen Inc. | Mutual Funds

Mutual Funds that own Amgen Inc.

Name

Shares Held

% Shares Out

Change In Shares

% of Assets

As of Date

Vanguard Total Stock Market Index Fund

16,632,947

2.57%

68,025

0.44%

07/31/2018

Vanguard 500 Index Fund

12,060,596

1.86%

13,617

0.54%

07/31/2018

Vanguard PRIMECAP Fund

11,540,750

1.78%

-172,450

3.31%

06/30/2018

American Funds Investment Company of America

10,145,601

1.57%

-179,451

2.21%

06/30/2018

American Funds Capital World Growth & Income Fund

7,762,139

1.2%

-12,000

1.73%

06/30/2018

SPDR S&P 500 ETF

7,362,984

1.13%

85,064

0.54%

09/06/2018

American Funds Capital Income Builder

7,114,680

1.1%

1.48%

06/30/2018

Government Pension Fund - Global (The)

6,645,559

1.03%

173,987

0.16%

12/31/2017

Vanguard Institutional Index Fund

6,443,485

7,763

0.54%

07/31/2018

American Funds AMCAP Fund

6,319,605

0.98%

06/30/2018

About Amgen

View Profile

Address	One Amgen Center Drive Thousand Oaks California 91320 United States
Employees	-
Website	http://www.amgen.com
Updated	07/08/2019
Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. Its products include the following brands: Aranesp, BLINCYTO, Corlanor, ENBREL, EPOGEN, IMLYGIC, KYPROLIS, Neulasta, NEUPOGEN, Nplate, Parsabiv, Prolia, Repatha, Sensipar, Vectibix, and XGEVA. The company was founded by William K.